Search Results
May 19, 2026, 08:45 ET Tattu Launches 5.0 Smart Battery Platform as Heavy-Lift Drones Demand Faster Charging and Smarter Fleet Power Management
maintenance and manage power assets with greater confidence."Tattu 5.0 represents our understanding of where the UAV industry is heading," said the Dr. Pi, R&D Expert at Grepow. "As heavy-lift drones become larger and more capable, the battery system must support not only power output, but also charging
More news about: Tattu
May 19, 2026, 08:13 ET Fiber-Alignment Stage Handles Photonics Applications with Loads to 2kg and Nanometer Precision
processes.SHREWSBURY, Mass., May 19, 2026 /PRNewswire/ -- Physik Instrumente (PI), a global leader in precision motion control and nanopositioning systems, introduces the F-572 High-Performance 3- to 6-Axis fiber-alignment stage and
More news about: Physik Instrumente (PI)
May 19, 2026, 08:00 ET Hellbender Secures $12.5M Seed Round to Accelerate Domestic Manufacturing of Physical AI and Launch Its On-Edge Camera Line
integration, Hellbender's new AI cameras allow software teams to focus purely on application development. Powered by Hailo AI accelerators and Raspberry Pi compute, they deliver low-power, high-TOPS processing directly to the edge. Today, the company is unveiling three new flagship products:Hellbender
More news about: Hellbender
May 19, 2026, 06:30 ET AVEVA and Amazon Web Services Announce Multi-Year Strategic Collaboration to Accelerate Industrial Intelligence in the Cloud
industrial data including reality capture, engineering, and production data serving more than 23,000 active monthly users across 50+ SaaS applications. The PI System, AVEVA's real-time operational data infrastructure, is deployed at 65% of Fortune 500 industrial companies and captures the time-series data that
More news about: AVEVA
May 19, 2026, 06:30 ET AVEVA and Amazon Web Services Announce Multi-Year Strategic Collaboration to Accelerate Industrial Intelligence in the Cloud
industrial data including reality capture, engineering, and production data serving more than 23,000 active monthly users across 50+ SaaS applications. The PI System, AVEVA's real-time operational data infrastructure, is deployed at 65% of Fortune 500 industrial companies and captures the time-series data that
More news about: AVEVA
May 19, 2026, 03:00 ET ROHM's Scalable Power Supply Solutions for Automotive SoCs; Combining PMIC and DrMOS for Optimal SoC Power Design and Future Performance
https://cdn.kyodonewsprwire.jp/prwfile/release/M106254/202605128856/_prw_PI1fl_5304RZD9.jpg The PMICs are housed in wettable flank QFN packages while the DrMOS is in a flip-chip QFN package.
More news about: ROHM Co., Ltd.
May 19, 2026, 03:00 ET ROHM's Scalable Power Supply Solutions for Automotive SoCs; Combining PMIC and DrMOS for Optimal SoC Power Design and Future Performance
https://cdn.kyodonewsprwire.jp/prwfile/release/M106254/202605128856/_prw_PI1fl_5304RZD9.jpg The PMICs are housed in wettable flank QFN packages while the DrMOS is in a flip-chip QFN package.
More news about: ROHM Co., Ltd.
May 18, 2026, 10:00 ET Major breakthrough of Sanyou Biopharmaceuticals AI-STAL
Lib.Fully Human Mouse Immune Ab Lib.Category II: Single-Domain Antibody LibrariesIncluding:Optimal-pI sdAb Lib.Humanized 2C sdAb Lib.Humanized 4C sdAb Lib.Alpaca Immune Ab Lib.Category III: Immune Antibody LibrariesIncluding:
More news about: Sanyou Bio
May 18, 2026, 07:54 ET Biotheryx Announces Data from its Phase 1 Dose Escalation Study of BTX-9341, a First-in-Class, Potent and Selective CDK4/6 Degrader, for the Treatment of Advanced/Metastatic HR+/HER2- Breast Cancer
post-CDK4/6 inhibitors with up to 6 prior lines of therapy in the metastatic setting; approximately 40% and 36% of participants had received chemotherapy and PI3K/AKT/mTOR or other targeted therapies, respectively. Clinical Benefit Rates1 (CBRs) of 41.7% and 80% were observed in treatment-evaluable
More news about: Biotheryx, Inc.
May 15, 2026, 08:41 ET NoMIS Power Joins ARPA-E DC-GRIDS Consortium, Supplying 3.3 kV SiC MOSFETs for High-Voltage HVDC Submodules
semiconductor technology, today announced its participation as an industry partner in a three-year, $2.5 million project led by Michigan State University (PI: Dr. Omid Beik) to develop high-voltage SiC-based Neutral Point Clamped Power Electronics Building Blocks (NPC-PEBBs) as vendor-agnostic,
More news about: NoMIS Power Corporation
May 14, 2026, 16:05 ET VALION BIO REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS
Salmonella FliC flagellin engineered to activate TLR5 selectively. Upon engagement, Entolimod triggers NF-κB-dependent signaling to stimulate G-CSF, PI3K, and IL-6 production, promote multi-tissue cytoprotection, and inhibit apoptosis in radiosensitive hematopoietic and gastrointestinal tissues. The compound
More news about: Valion Bio, Inc.
May 13, 2026, 09:02 ET DELFI Diagnostics to Present First Clinical Utility Data for Blood-Based Lung Cancer Screening at ATS 2026 International Conference
Davis, physician, tenured faculty at Duke University, medical director of the Duke Center for Smoking Cessation, and PI of the Delfi L301 study, had this to say: "A central idea behind using a blood test for lung cancer screening is that a primary care provider will be
More news about: DELFI Diagnostics
May 12, 2026, 08:13 ET PI Accepts Gold in MassEcon Economic Impact Awards at Gillette Stadium in Foxborough, MA
semiconductor manufacturing, aerospace, photonics, life sciences, and advanced research applications."PI is proud to receive this recognition from MassEcon," said Matt Reck, Co-Managing Director of PI USA. "Massachusetts is home to outstanding engineering talent and a culture of innovation. Our continued
More news about: Physik Instrumente (PI)
May 12, 2026, 07:57 ET IFAT Munich 2026: Vary Tech, Evonik y SupeZET lanzan un paquete de reciclaje químico integral
https://www.linkedin.com/company/103059726/admin/page-posts/published/Youtube: www.youtube.com/@VARYTECH-pi5hfFoto - https://mma.prnewswire.com/media/2976607/image1.jpg Foto
More news about: Vary Tech
May 12, 2026, 07:54 ET IFAT Munich 2026: Vary Tech, Evonik और SupeZET ने उच्च गुणवत्ता वाले PPO और सर्कुलर नेफ्था के लिए वेस्ट प्लास्टिक के पूर्ण-चेन रासायनिक रीसाइक्लिंग पैकेज का शुभारंभ किया
https://www.linkedin.com/company/103059726/admin/page-posts/published/Youtube: www.youtube.com/@VARYTECH-pi5hfफ़ोटो - https://mma.prnewswire.com/media/2976607/image1.jpg फ़ोटो
More news about: Vary Tech
May 12, 2026, 02:00 ET ichi Antiquite's Botanical Print Shirt Illustrates Refined Natural Elegance, Introduced by miel
https://cdn.kyodonewsprwire.jp/prwfile/release/M108390/202604308406/_prw_PI1fl_383yIAxb.jpg Image2:
More news about: chambrette Corporation
May 11, 2026, 13:12 ET IFAT Munich 2026 : Vary Tech, Evonik et SupeZET lancent un programme de recyclage chimique complet des déchets plastiques en PPO de haute qualité et en naphta circulaire
https://www.linkedin.com/company/103059726/admin/page-posts/published/YouTube : www.youtube.com/@VARYTECH-pi5hfPhoto - https://mma.prnewswire.com/media/2976607/image1.jpg Photo
More news about: Vary Tech
May 11, 2026, 13:11 ET IFAT Munich 2026: Vary Tech, Evonik und SupeZET bringen Paket für chemisches Recycling von Kunststoffabfällen zu hochwertigem PPO und Kreislaufnaphtha auf den Markt
https://www.linkedin.com/company/103059726/admin/page-posts/published/Youtube: www.youtube.com/@VARYTECH-pi5hfFoto - https://mma.prnewswire.com/media/2976607/image1.jpg Foto
More news about: Vary Tech
May 11, 2026, 06:47 ET IFAT Munich 2026: Vary Tech, Evonik and SupeZET Launch Full-Chain Chemical Recycling Package for Waste Plastics to High-Quality PPO and Circular Naphtha
https://www.linkedin.com/company/103059726/admin/page-posts/published/Youtube: www.youtube.com/@VARYTECH-pi5hfPhoto - https://mma.prnewswire.com/media/2976607/image1.jpg Photo
More news about: Vary Tech
May 11, 2026, 06:15 ET IFAT Munich 2026: Vary Tech, Evonik and SupeZET Launch Full-Chain Chemical Recycling Package for Waste Plastics to High-Quality PPO and Circular Naphtha
https://www.linkedin.com/company/103059726/admin/page-posts/published/Youtube: www.youtube.com/@VARYTECH-pi5hf
More news about: Vary Tech
May 05, 2026, 17:01 ET Norgine welcomes TGA registration in Australia of PEDMARQSI® (sodium thiosulfate anhydrous) for the prevention of cisplatin-induced hearing loss in children1
group of companies.References: Australian Product Information, PEDMARQSI®: PEDMARQSI Product Information (PI). Accessed April 2026Brock PR, et al. N Engl J Med 2018; 378(25): 2376–2385Freyer DR, et al. Lancet Oncol 2017; 18(1):
More news about: Norgine
May 05, 2026, 17:01 ET Norgine begrüßt die TGA-Zulassung von PEDMARQSI® (Natriumthiosulfat wasserfrei) in Australien zur Vorbeugung von Cisplatin-induziertem Hörverlust bei Kindern1
Norgine-Unternehmensgruppe.Referenzen:Australische Produktinformation, PEDMARQSI®: PEDMARQSI Produktinformation (PI). Abgerufen im April 2026Brock PR, et al. N Engl J Med 2018; 378(25): 2376–2385Freyer DR, et al. Lancet Oncol 2017; 18(1):
More news about: Norgine
May 05, 2026, 17:01 ET Norgine welcomes TGA registration in Australia of PEDMARQSI® (sodium thiosulfate anhydrous) for the prevention of cisplatin-induced hearing loss in children1
group of companies.References: Australian Product Information, PEDMARQSI®: PEDMARQSI Product Information (PI). Accessed April 2026Brock PR, et al. N Engl J Med 2018; 378(25): 2376–2385Freyer DR, et al. Lancet Oncol 2017; 18(1):
More news about: Norgine
May 05, 2026, 17:01 ET Norgine celebra el registro de la TGA en Australia de PEDMARQSI®
empresas Norgine.Referencias:Australian Product Information, PEDMARQSI®: PEDMARQSI Product Information (PI). Consultado en abril de 2026Brock PR, et al. N Engl J Med 2018; 378(25): 2376–2385Freyer DR, et al. Lancet Oncol 2017;
More news about: Norgine
May 05, 2026, 17:01 ET Norgine se félicite de l'enregistrement par la TGA en Australie de PEDMARQSI® (thiosulfate de sodium anhydre) pour la prévention de la perte auditive induite par le cisplatine chez les enfants1
Norgine.Notes :Informations sur les produits australiens, PEDMARQSI®: PEDMARQSI Informations sur le produit (PI). Accédé en avril 2026Brock PR, et al. N Engl J Med 2018 ; 378(25) : 2376–2385Freyer DR, et al. Lancet Oncol 2017 ; 18(1)
More news about: Norgine